Company / Operating Cash Flow per Share
Abbott Laboratories Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$5.47
FY2025
5-year range
$3.45 / $5.89
FY2021-FY2025
Trend
+12.7%
vs FY2024
Sector context
#49 of 161
Health Care
What the data says
At $5.47, Abbott Laboratories's operating cash flow per share ranks #49 of 161 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $1.97 in FY2017 to $5.89 in FY2023.
Based on SEC 10-K filings.
5.47 in FY2025 with a 5-year CAGR of +9.0%.
Declined from $5.89 to $5.47 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +7.3%
- 5-Year CAGR
- +9.0%
- 10-Year CAGR
- -
Sector benchmark
#49 of 161 in Health CareTop 30% of 161This company $5.47 Sector average $6.64
▼
-17.7% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 12.7% year-over-year.
- Ranks #49 out of 161 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2023.
- Lowest operating cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 31.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 27.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.47 | +12.7% |
| FY2024 | $4.85 | -17.6% |
| FY2023 | $5.89 | +33.1% |
| FY2022 | $4.42 | +28.4% |
| FY2021 | $3.45 | -3.2% |
| FY2020 | $3.56 | +1.5% |
| FY2019 | $3.51 | +62.4% |
| FY2018 | $2.16 | +9.7% |
| FY2017 | $1.97 | -18.2% |
| FY2016 | $2.41 | +14.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026